Hjem › Gliom
Gliom kliniske forsøg rekrutterer i USA
118 studier for Gliom rekrutterer deltagere på steder over hele USA.
Byer med flest studier
- New York City, NY25 studier
- Houston, TX23 studier
- Boston, MA20 studier
- Washington, DC19 studier
- Philadelphia, PA16 studier
- Columbus, OH15 studier
- Miami, FL15 studier
- San Francisco, CA14 studier
- Chicago, IL13 studier
- Durham, NC12 studier
- Seattle, WA11 studier
- Los Angeles, CA10 studier
- St. Louis, MO10 studier
- Aurora, CO10 studier
- Rochester, MN9 studier
- Cincinnati, OH9 studier
- Edison, NJ7 studier
- Atlanta, GA7 studier
- Queens, NY7 studier
- Jacksonville, FL6 studier
- Baltimore, MD6 studier
- Omaha, NE6 studier
- San Diego, CA6 studier
- Birmingham, AL6 studier
- Dallas, TX6 studier
- Orange, CA6 studier
- Nashville, TN6 studier
- Cleveland, OH5 studier
- Ann Arbor, MI5 studier
- San Antonio, TX5 studier
- New Rochelle, NY5 studier
- Pittsburgh, PA4 studier
- New Haven, CT4 studier
- Detroit, MI4 studier
- Mountain View, CA4 studier
- Salt Lake City, UT4 studier
- Arlington, VA4 studier
- Tampa, FL4 studier
- Indianapolis, IN4 studier
- East Norwalk, CT4 studier
Efter delstat
- Alabama6 studier
- Arizona8 studier
- Arkansas3 studier
- Californien25 studier
- Colorado11 studier
- Connecticut6 studier
- District of Columbia14 studier
- Florida23 studier
- Georgia7 studier
- Illinois13 studier
- Indiana4 studier
- Iowa3 studier
- Maryland11 studier
- Massachusetts20 studier
- Michigan8 studier
- Minnesota13 studier
- Missouri11 studier
- Nebraska6 studier
- New Jersey10 studier
- New York28 studier
- North Carolina16 studier
- Ohio18 studier
- Pennsylvania19 studier
- Tennessee8 studier
- Texas26 studier
- Utah4 studier
- Virginia5 studier
- Washington11 studier
Nyligt opdaterede studier
Officiel studietekst (engelsk)
MCT for the Harvard/UCSF ROBIN Center
Rekrutterer
Alle aldre · Alle køn · Opdateret 1. okt. 2026 · NCT06000787Medication Combinations of Dasatinib, Quercetin, Fisetin, Temozolomide, LMP744, and Autologous TLPO Vaccine for the Treatment of Previously Treated Glioma With Residual Disease
RekruttererTidlig fase 1
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT07025226A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
RekruttererFase 1/2
12 Months – 21 Years · Alle køn · Opdateret 1. okt. 2026 · NCT05099003Preoperative Radiosurgery for the Treatment of High Grade Glioma, NeoGlioma Trial
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT05030298Language Network Prehab Via fMRI Neurofeedback
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 29. sep. 2026 · NCT07488780Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07326566Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
RekruttererFase 1/2
Alder 18 til 99 · Alle køn · Opdateret 28. sep. 2026 · NCT07416188A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
RekruttererFase 1/2
Op til 25 år · Alle køn · Opdateret 25. sep. 2026 · NCT04094610MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT03896568Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG
RekruttererTidlig fase 1
Alder 1 til 21 · Alle køn · Opdateret 22. sep. 2026 · NCT05555550ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
RekruttererFase 2
12 Months – 39 Years · Alle køn · Opdateret 21. sep. 2026 · NCT06838676Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 21. sep. 2026 · NCT04977375Development of MRF for Characterization of Brain Tumors After Radiotherapy
RekruttererFrivillige med god helbredstilstand velkomne
Alder 18 til 60 · Alle køn · Opdateret 15. sep. 2026 · NCT06101069A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors
RekruttererFase 1
Alder 5 til 18 · Alle køn · Opdateret 15. sep. 2026 · NCT06357377MRE Scan for the Assessment of Differences in Tissue Stiffness Between Radiation Necrosis and Recurrent Glioma in Patients With Previously Treated Gliomas
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 14. sep. 2026 · NCT04373720A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma
RekruttererFase 1
Alder 19 og opefter · Alle køn · Opdateret 14. sep. 2026 · NCT05698524Serial Advanced Magnetic Resonance Imaging Scan for Guidance of Personalized Adaptive Radiotherapy for High Grade Glioma
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 14. sep. 2026 · NCT04771806Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care Radiation
RekruttererFase 1
36 Months · Alle køn · Opdateret 9. sep. 2026 · NCT07076498NgFUS NIVO: NeuroNavigation-Guided Focused Ultrasound With Nivolumab in Relapsed and Progressive DMG and Other High Grade Brain Tumors
RekruttererFase 1
Alder 3 til 25 · Alle køn · Opdateret 9. sep. 2026 · NCT07664176Targeted Pediatric High-Grade Glioma Therapy
RekruttererObservationsstudie
12 Months – 39 Years · Alle køn · Opdateret 8. sep. 2026 · NCT05839379HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
RekruttererFase 1
36 Months – 22 Years · Alle køn · Opdateret 4. sep. 2026 · NCT03911388A Study of Mirdametinib in People With Central Nervous System Tumors
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 3. sep. 2026 · NCT07539441Assessing Brain Metabolism Using MRS With Deuterated Glucose
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 2. sep. 2026 · NCT06594315Study of Olutasidenib and Temozolomide in HGG
RekruttererFase 2
Alder 12 til 39 · Alle køn · Opdateret 1. sep. 2026 · NCT06161974Glioma Developmental and HyperActive Ras Tumor (DHART) Board
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 31. aug. 2026 · NCT05489783Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.